(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Bethesda North Marriott Hotel and Conference Center

2019年2月11日 (月) 午後 7:00 - 2019年2月13日 (水) 午後 8:15

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

戻る Agenda

Session 4: FDA – Electronic Submissions

Session Chair(s)

Ethan Chen, MBA, MS, PMP

Ethan Chen, MBA, MS, PMP

Director, Division of Data Management

FDA CDER, United States

During this session, FDA will provide a summary on electronic submissions. As of May 5, 2017 and May 5, 2018, eCTD is required for NDA, BLA, and ANDA and Commercial IND and DMF submissions, respectively. In addition, studies started as of December 17, 2016 are required to be submitted in standardized format when submitted to NDA, BLA, and ANDA (required for Commercial INDs if study start date is December 17, 2017 or later). FDA will provide an update on submission metrics, processing challenges, and best practices for successful submission.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the status of electronic submissions and validation at the FDA
  • Identify key components of lifecycle management for electronic submissions
  • Apply proposed best practices for handling daily submissions and ensuring validation standards are followed

    • Speaker(s)

    Ethan Chen, MBA, MS, PMP

    Technical Rejection Criteria for Study Data

    Ethan Chen, MBA, MS, PMP

    FDA CDER, United States

    Director, Division of Data Management

    Jonathan Resnick, PMP

    eCTD Submission Metrics and Guidance Update

    Jonathan Resnick, PMP

    FDA, United States

    Project Management Officer, OBI, OSP, CDER

    最新情報や機会を逃さないで

    DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。